Nicholas Grund insider trades

Open-market stock purchases and sales by Nicholas Grund, Chief Commercial Officer at Akebia Therapeutics, Inc, from SEC Form 4 filings since Jan 4, 2016.

Recent trades

DateStockTradeValue
Feb 2, 2026AKBA Akebia Therapeutics, IncSold$74.5K
Feb 2, 2026AKBA Akebia Therapeutics, IncSold$43.4K
Jan 30, 2026AKBA Akebia Therapeutics, IncBought (not open market)—
Jan 30, 2026AKBA Akebia Therapeutics, IncBought (not open market)—

Companies traded

  • AKBA Akebia Therapeutics, Inc: 3 sales, last Feb 2, 2026
  • AMAG Amag Pharmaceuticals Inc: other filings, last Mar 2, 2019

Get free alerts when Nicholas Grund files a new trade →